Synthesis and Preclinical Evaluation of [18F]FCHC for Neuroimaging of Fatty Acid Amide Hydrolase

详细信息    查看全文

• 作者：Timothy M. Shoup ; Ali A. Bonab ; Alan A. Wilson…
• 关键词：Key words ; [18F]FCHC ; Fatty acid amide hydrolase ; FAAH ; Positron emission tomography ; PET ; Rodents
• 刊名：Molecular Imaging and Biology
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：17
• 期：2
• 页码：257-263
• 全文大小：1,182 KB
• 参考文献：1. Dainese, E, Fabritiis, G, Sabatucci, A (2014) Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH. Biochem J 457: pp. 463-472 CrossRef
  2. Cravatt, BF, Giang, DK, Mayfield, SP (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: pp. 83-87 CrossRef
  3. McKinney, MK, Cravatt, BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74: pp. 411-432 CrossRef
  4. Bracey, MH, Hanson, MA, Masuda, KR (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298: pp. 1793-1796 CrossRef
  5. Ahn, K, McKinney, M, Cravatt, B (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108: pp. 1687-1707 CrossRef
  6. Tsou, K, Nogueron, MI, Muthian, S (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Letters 254: pp. 3137-3140 CrossRef
  7. Egertová, M, Cravatt, BF, Elphick, MR (2003) Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neurosci 119: pp. 481-496 CrossRef
  8. Naidu, PS, Kinsey, SG, Guo, TL (2010) Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase. J Pharmacol Exp Ther 334: pp. 182-190 CrossRef
  9. Schlosburg, JE, Kinsey, SG, Lichtman, AH (2009) Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS J 11: pp. 39-44 CrossRef
  10. Fowler, CJ, Naidu, PS, Lichtman, A (2009) The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1. Br J Pharmacol 156: pp. 412-419 CrossRef
  11. Ahn, K, Johnson, DS, Mileni, M (2009) Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16: pp. 411-420 CrossRef
  12. Jayamanne, A, Greenwood, R, Mitchell, VA (2006) Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147: pp. 281-288 CrossRef
  13. Pillarisetti, S, Alexander, CW, Khanna, I (2009) Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases. Drug Discov Today 14: pp. 1098-1111 CrossRef
  14. Battista, N, Bari, M, Tarditi, A (2007) Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes. Neurobiol Dis 27: pp. 108-116 CrossRef
  15. Malone, DT, Kearn, CS, Chongue, L (2008) Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats. Neurosci 152: pp. 265-272 CrossRef
  16. Moreira, FA, Kaiser, N, Monory, K (2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuro
• 刊物主题：Imaging / Radiology;
• 出版者：Springer US
• ISSN：1860-2002

文摘

Purpose Fatty acid amide hydrolase (FAAH), a catabolic enzyme which regulates lipid transmitters in the endocannabinoid system, is an avidly sought therapeutic and positron emission tomography (PET) imaging target for studies involving addiction and neurological disorders. We report the synthesis of a new fluorine-18-labeled FAAH inhibitor, trans-3-(4, 5-dihydrooxazol-2-yl)phenyl-4-[18F]fluorocyclohexylcarbamate ([18F]FCHC), and its evaluation in rat brain. Procedures The synthesis of [18F]FCHC was conducted via a 3-step, 1-pot reaction, resulting in uncorrected radiochemical yields between 10 and 20?% (n--) relative to [18F]fluoride, with specific activities of >5?Ci/μmol at the end of the synthesis. The radiosynthesis was seamlessly automated using a commercial radiofluorination apparatus. Ex vivo biodistribution and preliminary PET imaging studies were carried out in male Sprague-Dawley rats. Results Rat brain biodistribution at 2?min post-injection showed a standard uptake value of 4.6?±-.1 in the cortex, which increased to 7.8?±-.1 at 40?min. Pretreatment with the selective FAAH inhibitor URB597 reduced uptake of radioactivity in all brain regions by >90?%, with 98?% blockade in the FAAH-rich cortex. PET imaging was consistent with biodistribution studies. Conclusions [18F]FCHC appears to be a highly sensitive 18F-labeled radiotracer for imaging FAAH in the central nervous system, and these results warrant further imaging in nonhuman primates.